60 Degrees Pharmaceuticals, Inc.
SXTP
$0.95
-$0.02-2.40%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 23.41% | 63.90% | 106.84% | 202.12% | 128.69% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 23.41% | 63.90% | 106.84% | 202.12% | 128.69% |
| Cost of Revenue | 28.46% | -49.08% | -47.25% | -36.04% | -31.60% |
| Gross Profit | -31.72% | 68.74% | 69.64% | 63.39% | 52.91% |
| SG&A Expenses | 6.87% | 14.62% | 26.08% | 26.56% | 18.57% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 13.10% | -16.48% | -11.81% | -7.23% | -7.38% |
| Operating Income | -11.79% | 22.75% | 20.12% | 17.14% | 13.93% |
| Income Before Tax | -3.73% | 26.10% | 7.36% | -0.33% | -383.32% |
| Income Tax Expenses | -200.00% | -1,400.00% | -- | -155.56% | -171.43% |
| Earnings from Continuing Operations | -3.71% | 26.12% | 7.38% | -0.32% | -383.14% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -51.52% | -52.17% | -62.79% | -82.90% | -86.13% |
| Net Income | -3.76% | 26.10% | 7.32% | -0.72% | -397.33% |
| EBIT | -11.79% | 22.75% | 20.12% | 17.14% | 13.93% |
| EBITDA | -11.42% | 23.21% | 20.56% | 17.54% | 14.26% |
| EPS Basic | 83.81% | 91.17% | 85.32% | 87.46% | -327.82% |
| Normalized Basic EPS | 83.86% | 91.44% | 85.31% | 87.26% | 83.29% |
| EPS Diluted | 83.81% | 91.17% | 85.32% | 87.46% | -327.82% |
| Normalized Diluted EPS | 83.86% | 91.44% | 85.31% | 87.26% | 83.29% |
| Average Basic Shares Outstanding | 505.94% | 456.67% | 488.95% | 671.55% | 652.44% |
| Average Diluted Shares Outstanding | 505.94% | 456.67% | 488.95% | 671.55% | 652.44% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |